| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |